Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to protect female asylum seekers from sexual violence

NCT ID NCT07477314

Prevention Sponsor: Assistance Publique Hopitaux De Marseille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test whether a coordinated care model, including a care coordinator and a health mediator, can prevent sexual violence among 675 female asylum seekers in France. Participants will be randomly assigned to either this coordinated care or usual care. The main goal is to see if the coordinated model reduces the occurrence of sexual violence within 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
coordinated care model (care coordinator and health mediator)
What this could lead to
If successful, this could provide an effective way to prevent sexual violence and improve health outcomes for female asylum seekers.
What could go wrong
This is an early-stage study that has not yet started recruiting. The coordinated care model may not reduce violence more than usual care, and results may not apply to other countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 675 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Female seeking asylum in France

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Woman seeking asylum in France * Asylum application registered less than 3 months before inclusion. * Self-identified female gender. * Age ≥ 18 years. * Received study information and provided informed consent to participate Exclusion Criteria: * Re-examination of a previous asylum application. * Major cognitive impairment (e.g. dementia or intellectual disability) preventing reliable collection of study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Access to recommended healthcare are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Access to recommended healthcare Mental health Physical health Quality of life Refugee health Sexual violence

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • MSP Mathagon

    Paris, France

  • MSP soins premiers Villeurbanne Est

    Lyon, France

  • Maison de Santé Butte Sainte Anne

    Nantes, France

  • Maison de Santé PEYSSONEL

    Marseille, France

  • Maison de Santé de Saint André

    Bordeaux, France

  • Maison de santé Bonnefoy Périole Roseraie

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.